
Please try another search
Viveve Medical, Inc. designs, develops, manufactures, and markets a platform medical technology, Cryogen-cooled Monopolar Radiofrequency (CMRF). The Company's CMRF technology is delivered through a radiofrequency (RF) generator, handpiece and treatment tip, that collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence (SUI), which is known as Viveve treatment. The Viveve System uses a method of delivering monopolar radiofrequency (RF) energy for treating tissue, such as Monopolar Radiofrequency Energy. The Viveve System also uses a cryogen surface cooling that enables volumetric heating of vaginal tissue. The Viveve System also uses a proprietary, controlled cryogen surface cooling that enables deep volumetric heating of vaginal tissue. The Company's subsidiary includes Viveve, Inc. and Viveve BV.
Name | Age | Since | Title |
---|---|---|---|
Roger Roman Dmochowski | - | - | Member of Clinical Advisory Board in Urinary Incontinence |
Scott A. MacDiarmid | - | - | Member of Clinical Advisory Board in Urinary Incontinence |
Mickey M. Karram | - | - | Member of Clinical Advisory Board in Urinary Incontinence |
Alan J. Wein | - | - | Member of Clinical Advisory Board in Urinary Incontinence |
Kathleen C. Kobashi | - | - | Member of Clinical Advisory Board in Urinary Incontinence |
Eric S. Rovner | - | - | Member of Clinical Advisory Board in Urinary Incontinence |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review